Craft

ILIAS Biologics

Total Funding

$37.6 M

ILIAS Biologics Summary

Company Summary

Overview
ILIAS Biologics is a biotechnology company of exosome therapeutics. Its platform, EXPLOR, makes it possible to load large therapeutic molecules into exosomes and then develop various therapeutic exosomes, Exo-Targets, as potential treatments for sepsis, pre-term birth, and various hard-to-treat diseases in inflammatory and metabolic areas.
Type
Private
Status
Active
Founded
2015
HQ
Daejeon, KR | view all locations
Website
http://www.iliasbio.com/
Cybersecurity rating
Sectors

Key People

  • Chulhee Choi

    Chulhee Choi, Chief Executive Officer

  • Jun Tae Park

    Jun Tae Park, EVP, Chief Scientific Officer

  • Taejin Ham

    Taejin Ham, EVP, Chief Operating Officer

  • Sangchul Kim

    Sangchul Kim, Executive Vice President

    LocationsView all

    5 locations detected

    • Daejeon, Daejeon HQ

      Korea (Republic of)

      40-20 Techno 6-ro, Gwanpyeong-dong, Yuseong-gu

    • Gilroy, CA

      United States

      7880 Wren Ave

    • Seoul

      Korea (Republic of)

      24-2 Samseong-ro 100-gil, Samseong-dong, Gangnam-gu

    • Seongnam-si, Gyeonggi-do

      Korea (Republic of)

      16 Daewangpangyo-ro 712 chilbaeks, Sampyeong-dong, Bundang-gu

    • Seoul, Seoul

      Korea (Republic of)

      117-3 Hoegi-ro, Hoegi-dong, Dongdaemun-gu

    Footer menu